title stringlengths 1 1.19k | keywords stringlengths 0 668 | concept stringlengths 0 909 | paragraph stringlengths 0 61.8k | PMID stringlengths 10 11 |
|---|---|---|---|---|
Sample size calculation | OA knee | OA KNEE, OSTEOARTHRITIS | The exercise effect on OA knee patients was investigated using the G power software, which detected a difference in WOMAC (Western Ontario and McMaster Universities Osteoarthritis) index stiffness from 3.66 ± 2.64 to 2.10 ± 2.26 [The formula used for sample size calculation is | PMC10522526 |
Outcome measurement tools | PMC10522526 | |||
Numerical pain rating scale (NRS) | pain | The average pain intensity was measured during the past week, with zero representing no pain and ten representing the worst pain [ | PMC10522526 | |
Goniometric measurement for ROM | knee flexion and extension ROM | Both the knee flexion and extension ROM were measured while the subject was in a prone position. The measurement was done three times and the average result was obtained. | PMC10522526 | |
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) | lower extremity osteoarthritis, pain | KNEE OSTEOARTHRITIS | The questionnaire was developed to measure treatment outcomes in patients with lower extremity osteoarthritis, such as pain, stiffness, and difficulty, and it employs a scale to categorize the difficulties in activities of daily living. For individuals with hip and knee osteoarthritis, the WOMAC scale is a valid and re... | PMC10522526 |
Timed Up and Go (TUG) test | The test combines static and dynamic balance to assess a person’s mobility. Getting out of a chair, walking three meters, turning around, and returning to the chair to sit. The international research OA society recommends a series of physical function measures (five performance-based) for individuals with hip or knee O... | PMC10522526 | ||
Interventions | HEAT | All patients received 15 min of moist heat from a hydro collator pack wrapped in a soft towel put around the afflicted knee before beginning the main treatment. In one experimental group, KT followed by TENS was applied. After that, an exercise program was started. The other experimental group was followed by TENS and ... | PMC10522526 | |
Kinesio taping — 2 times per week for 6 weeks | knee joint effusion | The professionally trained physical therapist applied Kinesio taping twice a week for the entire 6-week study period. The patient is in a supine position with full knee flexion. Before application, the skin surface was cleaned. This technique involved the use of two Y-cut strips and two I-cut strips. On the two Y-cut s... | PMC10522526 | |
Transcutaneous electrical nerve stimulation (TENS) — 2 times per week for 6 weeks | tingling sensation | In our study, we used the following TENS device settings, such as the frequency of 32–50 Hz, the pulse width of 80 ms, and symmetrical biphasic waveform. The surface electrodes were placed on the medial and lateral superior borders of the patella, as well as the medial and lateral inferior borders of the patella. The e... | PMC10522526 | |
Exercise therapy program | The exercise therapy training program continued for six weeks, two days every week. The recommended American Geriatrics Society exercise program was used in this study [ | PMC10522526 | ||
Statistical methods | To reveal the patients’ demographic profile concerning the outcome parameters, a descriptive statistic was applied. Furthermore, two-way mixed ANOVA and Tukey HSD post hoc tests were used to analyze within-group and between-group comparisons in SPSS 20.0. | PMC10522526 | ||
Discussion | knee flexion ROM, a loss of muscle strength [The TUG test, pain | ADVERSE EFFECTS, OSTEOARTHRITIS | Our research results showed the majority of knee OA patients tolerated the 6-week course of Kinesio Tex Gold FP (5 cm × 5 m) knee taping very well. There were no significant adverse effects or functional deterioration that would force the intervention to be discontinued. Clinically relevant improvements in pain, knee f... | PMC10522526 |
Recommendations | Large sampling, well-structured study design, and randomized controlled trials in multiple centers are needed to assess the long-term effects of Kinesio taping combined with conventional physical therapy versus conventional physical therapy alone for knee OA. | PMC10522526 | ||
Study limitations | The study sample was limited to the male gender only. There was also no control group, so the improvement in the usual care group could be attributed to normal resolution. | PMC10522526 | ||
Conclusions | knee osteoarthritis, pain | KNEE OSTEOARTHRITIS | Kinesio taping plus conventional physical therapy showed statistically significant effects on pain reduction, increased range of motion, and improved functional activity in the third week and was similarly effective in the sixth week of treatment in patients with knee osteoarthritis. TENS and exercise programs for knee... | PMC10522526 |
Acknowledgements | I would like to thank all of the patients who participated in the study, as well as physical therapist Mr. Mohammed Alobaid of King Fahd Specialist Hospital in Tabuk, who helped with data collection. Physical therapists Mr. Sohail Mohammed Albalawi and Mr. Ali Mohammed Altdlawi arranged facilities in the hospital setti... | PMC10522526 | ||
Funding | This study was supported by grants from the Deanship of Scientific Research (S-1440–0070), University of Tabuk, Ministry of Higher Education, Kingdom of Saudi Arabia. | PMC10522526 | ||
Declarations | PMC10522526 | |||
Conflict of interest | The authors declare no competing interests. | PMC10522526 | ||
References | PMC10522526 | |||
Background | UCDs | URINARY TRACT INFECTION (UTI), MSU | Up to 30% of urine samples from women with suspected urinary tract infection (UTI) are contaminated and need to be repeated, burdening health services and delaying antibiotic prescription. To prevent contamination, midstream urine (MSU) sampling, which can be difficult to achieve, is recommended. Urine collection devic... | PMC10170521 |
Aim | UCDs | UTI | To explore women’s experiences of urine collection and the use of UCDs during a suspected UTI. | PMC10170521 |
Design and setting | UCDs | UTI | An embedded qualitative study in a UK randomised controlled trial (RCT) of UCDs among women attending primary care for UTI symptoms. | PMC10170521 |
Method | Semi-structured telephone interviews with 29 women who had participated in the RCT were conducted. The transcribed interviews were then thematically analysed. | PMC10170521 | ||
Results | UCDs | UTI | Most of the women were dissatisfied with how they normally produced urine samples. Many were able to use the devices, found them hygienic, and would use them again, even if they had initially experienced problems. Women who had not used the devices expressed interest in trying them. Potential barriers to UCD use includ... | PMC10170521 |
Conclusion | UCDs | UTI | Most women agreed there was a need for a user- and environmentally-friendly device to improve urine collection. Although using UCDs can be difficult for women experiencing UTI symptoms, they may be appropriate for asymptomatic sampling in other clinical populations. | PMC10170521 |
INTRODUCTION | fits, bacterial infections | URINARY TRACT INFECTION (UTI), BACTERIAL INFECTIONS | Among the bacterial infections managed in primary care, urinary tract infection (UTI) is one of the most common and accounts for 1%–3% of GP consultations.To avoid contamination, patients are often advised to discard the first portion of the urine stream, in which the majority of any contaminants may be present, and to... | PMC10170521 |
METHOD | PMC10170521 | |||
Design | Investigation of these issues using qualitative research methods was chosen given the lack of relevant literature and the suitability of qualitative research for investigating individuals’ experiences and perceptions of actions and processes. Semi- structured individual interviews enable researchers to explore topics o... | PMC10170521 | ||
Setting and participants | pain | BLOOD IN THE URINE, RECRUITMENT, UTI | The RCT recruited adult women (aged 20 years–88 years) presenting to UK general practice with symptoms of UTI, experiencing at least one of: pain on urination; blood in the urine; or frequency of urination; and who were able to give informed consent to take part in the RCT. All RCT participants were asked if they were ... | PMC10170521 |
Data collection | UTIs, UCDs | MSU | An interview topic guide was developed, taking into account the available literature, which covered issues of interest relating to the UCDs and the women’s wider experiences of providing urine samples at times of suspected UTIs, such as their usual methods of collecting urine, their awareness of the need for MSU sampli... | PMC10170521 |
Analysis | The interviews were audiorecorded, transcribed verbatim by a transcription company, and the transcripts checked and anonymised. The data was analysed thematically using NVivo (version 11) to retrieve and organise the data. The researchers read and re-read the transcripts, undertook systematic coding of the data, and es... | PMC10170521 | ||
RESULTS | anddifficulties, UCDs | RECRUITMENT, UTI | In total, 29 women participated in interviews; 13 from the Peezy arm, 13 from the Whiz Midstream arm, and three from the standardised practice arm. Three women declined to take part in the interview study when they were contacted after their participation in the trial ended. The focus was on recruitment among women who... | PMC10170521 |
Experiences of using a UCD | PMC10170521 | |||
Acceptability of UCDs | UCDs | Participants also expressed more general views about the acceptability of UCDs. These were related to hygiene, disposal, and cost. | PMC10170521 | |
DISCUSSION | PMC10170521 | |||
Summary | confusion, UCDs, pain, reduced vision, UTIs | MSU, MOVEMENT DISORDERS, UTI | For many of the women, their motivation for trying out the UCDs was rooted in their dissatisfaction with how they normally produced urine samples at times of a suspected UTI. The study found that most of the women were not aware of the need for MSU samples and the problem of contamination of the samples until these wer... | PMC10170521 |
Strengths and limitations | UTIs | A strength of this study is the range of participants interviewed, particularly across the age groups. The authors found qualitative interviews a very useful method for collecting data about a highly personal issue such as UTIs, and the women felt able to speak with candour and in detail about their experiences.The wom... | PMC10170521 | |
Comparison with existing literature | UCDs | UTI | Although some of the participants in the current study encountered difficulties in using the UCDs because of UTI symptoms, they suggested that the devices might be particularly suitable for pregnant women. In one other study, a UCD (the Whiz Midstream) was compared with conventional urine collection methods in women at... | PMC10170521 |
Implications for practice | UCDs | UTI | In this study most women confirmed there was an unmet need for a device to improve urine sample collection. The struggles described by these participants when using smaller containers that are usually used in existing practice suggest that more user-and environmentally-friendly collection devices are needed. Some women... | PMC10170521 |
Funding | This project was funded by
| PMC10170521 | ||
Ethical approval | Ethical approval was received from the East of England — Cambridge East Research Ethics Committee (reference: 16/EE/0200). | PMC10170521 | ||
Provenance | Freely submitted; externally peer reviewed. | PMC10170521 | ||
Competing interests | The authors have declared no competing interests. | PMC10170521 | ||
Discuss this article | Contribute and read comments about this article: | PMC10170521 | ||
REFERENCES | PMC10170521 | |||
Background | post-phacoemulsification | To determine the effect of ketorolac tromethamine 0.5% in preventing post-phacoemulsification macular thickening. This randomized clinical trial. patients randomized 1:1 to receive either topical ketorolac three times a day or a placebo. | PMC10347851 | |
Methods | diabetic, CMT | PROLIFERATIVE DIABETIC RETINOPATHY | A total of 101 eyes of 101 diabetic patients who were scheduled for phacoemulsification and had normal macular contour and thickness enrolled consecutively. The topical ketorolac and placebo were prescribed on the day before surgery and continued up to 4 weeks after surgery. Patients with proliferative diabetic retinop... | PMC10347851 |
Results | CMT | 49 eyes in the case group and 52 eyes in the control group were analyzed. Mean BCVA was significantly improved in both groups at all follow-ups (P < 0.001 for all). There was no statistically significant difference regarding the BCVA in different time points except week 12 (P = 0.028) among the study group. In the case... | PMC10347851 | |
Conclusion | diabetic, post-phacoemulsification | Based on our findings, topical ketorolac tromethamine 0.5% is not effective in the prevention of post-phacoemulsification macular thickening in diabetic patients. | PMC10347851 | |
Trail registration | The study protocol was registered into | PMC10347851 | ||
Clinical trial registration number | NCT03551808. | PMC10347851 | ||
Keywords | PMC10347851 | |||
Background | cataract, Cataract, diabetic, visual impairment | CATARACT, POSTOPERATIVE COMPLICATIONS, RETINA, CATARACT, MACULAR EDEMA | Cataract is a common cause of visual impairment in elderly individuals all around the world [In spite of the recent improvements in the surgical techniques of phacoemulsification, some postoperative complications have been reported. A higher percentage of macular edema (ME) was reported in diabetic patients (12%) compa... | PMC10347851 |
Methods | cataract, diabetic | CATARACT | In this randomized clinical trial (RCT), a total of 101 eyes from 101 diabetic patients who were scheduled for cataract surgery at Torfeh Medical Center, Shahid Beheshti University of Medical Sciences were included. The study protocol was registered into The study adhered to the tenets of the Declaration of Helsinki an... | PMC10347851 |
Participants | diabetic retinopathy, Comprehensive visual and ocular examinations, 78D, inflammation, uveitis, hazy, cataract, Diabetic, glaucoma, CMT, diabetes with fasting blood sugar, diopter | DIABETIC RETINOPATHY, INTRAOPERATIVE COMPLICATIONS, IOL, INFLAMMATION, UVEITIS, RECRUITMENT, CATARACT, PROLIFERATIVE DIABETIC RETINOPATHY (PDR), LENS, MACULAR DISEASE, GLAUCOMA, REFRACTIVE ERROR | Diabetic patients who were scheduled to undergo cataract surgery were included. All patients had controlled diabetes with fasting blood sugar (FBS) of 126 mg/dl or less and glycated hemoglobin A1c (HbA1c) of less than 7% at the time of study entry. Patients with glaucoma, uveitis, any previous intraocular surgery, any ... | PMC10347851 |
Surgical technique | IOL, LEAKAGE | The procedure was performed under topical or general anesthesia, according to the patient’s condition, by a single anterior segment surgeon (HMR). After a 2.8 mm clear corneal incision, phacoemulsification was performed using the divide and conquer technique, and the IOL was inserted in the capsular bag using the Monar... | PMC10347851 | |
Follow-up examinations | SURGICAL COMPLICATIONS | All patients were routinely examined the next day, one week, and one month after the surgery for possible surgical complications. Follow-up examinations including OCT imaging and BCVA measurement were conducted at the three-time points of 6, 12, and 24 weeks following the surgery for both cases and controls. | PMC10347851 | |
Randomization | All participants were randomly assigned into study groups of cases and controls using the permuted block randomization method with a random block length of 2, 4, 6, and 8. The randomization list was generated by a computer-based program and the details of the random sequence were concealed from researchers. Whenever a ... | PMC10347851 | ||
Blinding | Evaluation of outcomes was performed by a researcher who was uninformed about the group assignment. The study protocol and the type of treatment were concealed from our participants. | PMC10347851 | ||
Sample size | diabetic, CMT | To have a power of 90% to detect a 30 μm difference of CMT in 12 weeks, we needed 50 subjects in each group. It was based on the assumed standard deviation of 0.26 which was obtained in the pilot phase of this study. The probable attrition of up to 30% and type one error of 0.05 were also considered. Fifty-eight diabet... | PMC10347851 | |
Outcome measures | The changes of CMT and BCVA at the three-time points of weeks 6, 12, and 24 compared to the baseline were considered as the primary outcome measures. | PMC10347851 | ||
Statistical analysis | The normal distribution of quantitative data was assessed by the Shapiro-Wilks test and Q-Q plot. To describe data, we used, mean and standard deviation, median and range, frequency and percentage. To compare the baseline variables between the two groups we used an independent t-test, Mann-Whitney test, chi-square test... | PMC10347851 | ||
Results | diabetic, diopter, NPDR, CMT | DIABETIC RETINOPATHY, PROLIFERATIVE DIABETIC RETINOPATHY | This study enrolled 116 eligible patients, but the data of 15 patients were not included in the statistical analysis due to miss follow-up Finally, a total of 101 eyes out of 101 diabetic patients (mean age of 64 ± 10 and range of 45 to 95 years) were included (Fig.
The flowchart of the present studyTable
Baseline ch... | PMC10347851 |
Discussion | diabetic retinopathy, diabetic ME, inflammation, cataract, diabetic, post-phacoemulsification, diabetes | DIABETIC RETINOPATHY, INFLAMMATION, FOLLOWING CATARACT SURGERY, CATARACT, INSULIN-DEPENDENT DIABETES MELLITUS, DIABETES | In the current Randomized Clinical Trial (RCT), we investigated the prophylactic effect of ketorolac eye drop on post-phacoemulsification macular thickening in diabetic patients. We found that prophylactic ketorolac tromethamine 0.5% initiated the day before the surgery and continued up to 4 weeks in addition to topica... | PMC10347851 |
Conclusions | diabetes, CMT | FOLLOWING CATARACT SURGERY, DIABETES | In conclusion, the current randomized clinical trial suggests that prophylactic topical ketorolac 0.5% three times a day might not decrease CMT and improve visual acuity compared to placebo following cataract surgery in patients with diabetes. However, further studies with larger sample sizes are recommended. | PMC10347851 |
Acknowledgements | We are grateful to the Ophthalmology Research Center of Shahid Beheshti University for collaborating on classifying and reviewing patients’ clinical information, as well as monitoring database registration. | PMC10347851 | ||
Authors’ contributions | Homayoun | Hossein Mohammad-Rabei and Hamideh Sabbaghi designed the study. Saeed Karimi served as an editor. Alireza Ramezani, Homayoun Nikkhah, and Mehdi Emamverdi served as editors and data collectors, and Mehdi Emamverdi also provided consultation. Kourosh Sheibani served as a consultant. Bahareh Kheiri and Mehdi Yaseri contri... | PMC10347851 | |
Funding | We confirm that none of the authors involved in this research article have any financial interest in the subject matter of the work. Additionally, we did not receive any funding for this study. | PMC10347851 | ||
Data Availability | The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request. | PMC10347851 | ||
Declarations | PMC10347851 | |||
Ethics approval and consent to participate | The study adhered to the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of the Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Informed consent was obtained from all subjects and/or their legal guardian(s). | PMC10347851 | ||
Consent for publication | Not applicable. | PMC10347851 | ||
Competing interests | The authors declare that they have no competing interests. | PMC10347851 | ||
References | PMC10347851 | |||
Objectives | muscle mass, ovarian cancer | OVARIAN CANCER | In ovarian cancer (OC), suboptimal muscle morphology (i.e., low muscle mass and density) is associated with poor clinical outcomes, yet little is known about the effect of interventions aimed at improving these measures. We investigated the effect of resistance exercise after first-line treatment on muscle mass and den... | PMC10132425 |
Methods | muscle mass | Fifteen OC survivors participated in supervised resistance exercise twice weekly for 12 weeks (in-clinic or by telehealth). Assessments included muscle mass and density (dual-energy X-ray absorptiometry, peripheral quantitative computed tomography), muscle strength (1-repetition maximum [1RM] chest press, 5RM leg press... | PMC10132425 | |
Results | lean mass | The median age was 64 (range 33–72) years, 10 women underwent neoadjuvant chemotherapy and five underwent adjuvant chemotherapy. All participants completed the intervention (median attendance = 92%; range 79–100%). Post-intervention improvements were observed for whole-body lean mass (1.0 ± 1.4 kg, | PMC10132425 | |
Conclusion | muscle mass | In this study, supervised resistance exercise effectively improved muscle mass and density, muscle strength, and physical functioning without deleterious effects on the pelvic floor. Considering the prognostic value of these outcomes, larger studies are needed to confirm the benefits of resistance exercise in OC suppor... | PMC10132425 | |
Supplementary Information | The online version contains supplementary material available at 10.1007/s00520-023-07754-y. | PMC10132425 | ||
Keywords | Open Access funding enabled and organized by CAUL and its Member Institutions | PMC10132425 | ||
Introduction | ovarian cancer, fatigue, anxiety, cancer, depressive | OVARIAN CANCER, CANCER | About 75% of ovarian cancer (OC) cases are diagnosed at an advanced stage (III or IV) [In recent years, research has highlighted the important role of skeletal muscle in cancer outcomes. Both suboptimal muscle morphology and muscle function (i.e., low muscle strength and physical function) are associated with poor trea... | PMC10132425 |
Methodology | PMC10132425 | |||
Setting and participants | illness or disorder | RECRUITMENT, BONE METASTASES | The research design was a prospective single-arm study. Women with histologically confirmed stage III or IV epithelial OC who completed first-line surgical and chemotherapy treatment between four and 12 weeks prior to participation were eligible. Participants were recruited from Sir Charles Gairdner Hospital and St Joh... | PMC10132425 |
Exercise intervention | PERIPHERAL NEUROPATHY | The 12-week exercise intervention was delivered in an exercise clinic or by telehealth (online via the Internet) based on participants’ preferences. Participants undertook two supervised exercise sessions (either in-clinic or by telehealth) and one unsupervised home-based exercise session/week on non-consecutive days. ... | PMC10132425 | |
Outcome measures | Outcome measures were assessed at baseline (week 0) and post-intervention (weeks 13 or 14) at the Edith Cowan University Exercise Medicine Research Institute, Perth, Western Australia. Demographic and health history data including age, marital status, education level, employment status, comorbidities, and current medic... | PMC10132425 | ||
Muscle morphology | upper-limb and lower-limb bone-free lean mass | Whole-body and regional bone-free lean mass and fat mass were assessed by dual-energy X-ray absorptiometry (DXA, QDR-1500; Hologic Discovery A, Waltham, MA, USA). Appendicular lean mass was derived from the sum of upper-limb and lower-limb bone-free lean mass [ | PMC10132425 | |
Muscle strength and physical function | Upper and lower body muscle strength was assessed using a one-repetition maximum (1RM) chest press and a five-repetition maximum (5RM) leg press [ | PMC10132425 | ||
Patient-reported outcomes | nausea, dyspnea, fatigue, diarrhea, pain, constipation, insomnia, Cancer | APPETITE LOSS, CANCER | Disease-specific health-related QoL was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) version 3.0. The QLQ-C30 incorporates five functional scales (physical, role, cognitive, emotional, and social), nine symptom scales (fatigue, pain,... | PMC10132425 |
Statistical analysis | For a single-arm pre- and post-intervention study with alpha at 0.05 and 80% power, 15 participants provide the ability to detect an effect size of 0.8. Data were analyzed with SPSS Version 28 statistical software (IBM Corp., NY). Variables were assessed for normality using the Shapiro-Wilk test. Results for frequency ... | PMC10132425 | ||
Results | PMC10132425 | |||
Participant characteristics | Between September 2019 and September 2021, 16 of 29 eligible women were recruited (Fig. Participant flowchartPatient characteristicsAbbreviations: | PMC10132425 | ||
Exercise intervention | muscular pain, chest pain | ADVERSE EVENTS | Twelve women (80%) chose to participate in person in the exercise clinic. The three women (20%) who opted for the online intervention indicated travel distance to the exercise clinics as the reason. The median attendance of the 24 scheduled supervised sessions was 92% (range 79–100%). Participants indicated reasons for... | PMC10132425 |
Muscle morphology | From pre- to post-intervention, body weight increased by 1.4 ± 1.7 kg (Pre- and post-intervention measures of body composition, muscle morphology, muscle strength, and physical functionMuscle strengthAbsolute strengthAbbreviations: Values are presented as mean (SD) unless otherwise specifiedpQCT values, Leg press Chest... | PMC10132425 | ||
Muscle function | Over the 12-week intervention period, there was a significant increase in upper body absolute strength (+ 5.8 kg, 95% CI: 3.6–8.1, Individual changes from pre- to post-intervention—muscle strength and physical function. Lines and dots indicate individual data, with the box-and-whisker representation of the whole group.... | PMC10132425 | ||
Discussion | cancer, fatigue | CANCER | This study aimed to investigate the effect of supervised resistance exercise on muscle morphology and muscle function in advanced-stage OC survivors who had completed first-line treatment. There were two main findings. First, after 12 weeks of resistance exercise, there were significant increases in lean mass and muscl... | PMC10132425 |
Conclusion | fatigue | In this study, women with advanced-stage OC who recently completed first-line treatment experienced significant increases in lean body mass and muscle density, upper and lower body strength, and physical function after participating in resistance exercise. Clinically important improvements were also observed in fatigue... | PMC10132425 | |
Author contribution | Daniel A. | Christelle Schofield: conceptualization, methodology, investigation, formal analysis, project administration, and writing—original draft. Robert U. Newton: conceptualization, methodology, supervision, and writing—review and editing. Dennis R. Taaffe: conceptualization, methodology, formal analysis, and writing—review a... | PMC10132425 | |
Funding | Cancer | CANCER | Open Access funding enabled and organized by CAUL and its Member Institutions. CS was financially supported by an Edith Cowan University Ph.D. Scholarship, Australian Government Research Training Program Scholarship, and Western Australian Cancer Council Ph.D. Top-up Scholarship. | PMC10132425 |
Declarations | PMC10132425 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.